PharmaPack 2018:?The promises of digitalised medicine dont stop at injection pens or autoinjectors. One of the early adopters in the field is Swiss Haselmeier AG (Pharmapack: hall 7.1, booth L19). European Biotechnology spoke with Paul E. Jansen, Member of the Board, from Haselmeiers Boston office about how connected devices could define a new paradigm in therapy compliance and control of chronic diseases, and how they will shape the market.